Noninvasive low-grade papillary urothelial carcinoma with degenerative nuclear atypia: a grading pitfall

被引:2
|
作者
Matoso, Andres [1 ,2 ,3 ,4 ]
Parimi, Vamsi [1 ]
Epstein, Jonathan I. [1 ,2 ,3 ,4 ]
机构
[1] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21231 USA
[2] Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21231 USA
[3] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21231 USA
[4] Johns Hopkins Greenberg Bladder Canc Inst, Baltimore, MD 21231 USA
关键词
Bladder cancer; Papillary urothelial carcinoma; Grade; Degenerative atypia; Ki67; INVASIVE BLADDER-CANCER; PROGRESSION; RECURRENCE; MUTATIONS; UPDATE; NERVE;
D O I
10.1016/j.humpath.2021.04.002
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Noninvasive low-grade papillary urothelial carcinoma is a papillary neoplasm with orderly appearance and mild nuclear pleomorphism. Some cases show significant nuclear pleomorphism with degenerative atypia leading to grading difficulties. A retrospective review of the pathology files identified 16 cases diagnosed as noninvasive low-grade papillary urothelial carcinoma with degenerative atypia. Fifteen cases were consults. The average age was 46 years (range 19-78). The average size was 1.7 cm (range: 0.3-3.5). The submitting diagnoses in consults were noninvasive high-grade papillary urothelial carcinoma (n = 6), condyloma (n = 1), atypical papillary lesion (n = 1), prominent umbrella cells (n = 1), and not given (n = 6). Ki-67 proliferation rate was <5% in 10 of 10 cases (100%), and the cells with large atypical nuclei were negative. Microscopically, there were scattered cells with nuclei larger than 5 times the size of stromal lymphocytes but displayed smudgy chromatin and occasional multinucleation and intranuclear vacuoles. Next-generation sequencing identified the following mutations: HRAS (n = 4), FGFR3 (n = 3), KRAS (n = 3), BRAF (n = 1), PDGFRA (n = 1), and PIK3CA (n = 1). Other deleterious mutations were identified, but none in genes characteristic of high-grade tumors. Follow-up was available in 6 patients (median 32 months). One patient recurred with a noninvasive low-grade papillary urothelial carcinoma 20 months after the index case. All the remaining patients had no evidence of disease at the last follow-up. No patient died or had disease progression. The combination of preservation of polarity, low mitotic activity, Ki-67 <5% with the larger atypical nuclei negative for Ki-67, along with nuclear atypia that is degenerative are features used to classify these tumors as low grade. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [1] PTEN loss in noninvasive low-grade papillary urothelial carcinoma
    Arslankoz, S.
    Netto, G. J.
    Baydar, D. Ertoy
    VIRCHOWS ARCHIV, 2016, 469 : S231 - S232
  • [2] Nuclear features of infiltrating urothelial carcinoma are distinguished from low-grade noninvasive papillary urothelial carcinoma by image analysis
    Kosuge, Noritake
    Saio, Masanao
    Matsumoto, Hirofumi
    Aoyama, Hajime
    Matsuzaki, Akiko
    Yoshimi, Naoki
    ONCOLOGY LETTERS, 2017, 14 (03) : 2715 - 2722
  • [3] Prognostic Significance of Mitotic Activity in Noninvasive, Low-Grade, Papillary Urothelial Carcinoma
    Akkalp, Ash Kahraman
    Cakir, Omer Onur
    Tetikkurt, Unet Sez
    Tolga, Deniz
    Ozsoy, Sule
    Muslumanoglu, Ahmet Yaser
    ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY, 2016, 38 (01): : 23 - 30
  • [4] PUNLMP and Low-Grade Noninvasive Papillary Urothelial Carcinoma Are Indistinguishable by Prognosis and Molecular Subtype
    Jackson, Chelsea
    Chen, Lina
    Hardy, Celine
    Sjodahl, Gottfrid
    Siemens, D.
    Berman, David
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 570 - 571
  • [5] PUNLMP and Low-Grade Noninvasive Papillary Urothelial Carcinoma Are Indistinguishable by Prognosis and Molecular Subtype
    Jackson, Chelsea
    Chen, Lina
    Hardy, Celine
    Sjodahl, Gottfrid
    Siemens, D.
    Berman, David
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 570 - 571
  • [6] Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder*
    Reis, Leonard O.
    Taheri, Diana
    Chaux, Alcides
    Guner, Gunes
    Rodriguez, Maria A. Mendoza
    Bivalacqua, Trinity J.
    Schoenberg, Mark P.
    Epstein, Jonathan I.
    Netto, George J.
    HUMAN PATHOLOGY, 2016, 47 (01) : 20 - 25
  • [7] Low-grade Ta (noninvasive) urothelial carcinoma of the bladder
    Oosterlinck, W
    Solsona, E
    Akaza, H
    Busch, C
    Goebell, PJ
    Malmström, PU
    Özen, H
    Sved, P
    UROLOGY, 2005, 66 (6A) : 75 - 89
  • [8] Clinical Significance of Focal High-Grade Component in an otherwise Noninvasive Low-Grade Papillary Urothelial Carcinoma
    Saikia, Kasturi
    Bava, Ejas Palathingal
    Zia, Shereen
    Rodgers, Shannon
    Gupta, Siya
    Schultz, Daniel
    Gupta, Nilesh
    Hassan, Oudai
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 660 - 661
  • [9] Clinical Significance of Focal High-Grade Component in an otherwise Noninvasive Low-Grade Papillary Urothelial Carcinoma
    Saikia, Kasturi
    Bava, Ejas Palathingal
    Zia, Shereen
    Rodgers, Shannon
    Gupta, Siya
    Schultz, Daniel
    Gupta, Nilesh
    Hassan, Oudai
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 660 - 661
  • [10] Quantitative Nuclear Grading: An Objective, Artificial IntelligenceeFacilitated Foundation for Grading Noninvasive Papillary Urothelial Carcinoma
    Slotman, Ava
    Xu, Minqi
    Lindale, Katherine
    Hardy, Celine
    Winkowski, Dan
    Baird, Regan
    Chen, Lina
    Lal, Priti
    van der Kwast, Theodorus
    Jackson, Chelsea L.
    Gooding, Robert J.
    Berman, David M.
    LABORATORY INVESTIGATION, 2023, 103 (07)